Navigation Links
Stem Cell, Bone Marrow Transplants Both Benefit Leukemia Patients
Date:2/1/2010

Little difference in survival found 10 years after therapies, study says

MONDAY, Feb. 1 (HealthDay News) -- Long-term survival rates are similar for leukemia patients who've had either peripheral blood stem cell (PBSC) or bone marrow transplants, a new European study says.

The study began with 329 leukemia patients who received either PBSC or bone marrow transplants from a matched sibling donor between 1995 and 1999. Detailed information was collected on all the patients who survived longer than three years after their transplant.

Ten years after transplantation, 49.1 percent of PBSC recipients and 56.5 percent of bone marrow transplant recipients were still alive. Chronic graft versus host disease was more common among PBSC transplant patients (73 percent) than among bone marrow transplant patients (54 percent), and more PBSC recipients needed immunosuppressive treatment five years after transplantation (26 percent vs. 12 percent). But this did not affect the PBSC recipients' general health status or their ability to return to work, the study found.

The researchers also noted a trend toward improved, but not statistically significant, leukemia-free survival and overall survival after bone marrow transplant in patients with acute leukemias. Among patients with acute lymphoblastic leukemia, 10-year leukemia-free survival probability was 28.3 percent in the bone marrow transplant group, compared with 13 percent in the PBSC transplant group.

In patients with acute myeloid leukemia, the rates were 62.3 percent for bone marrow transplant and 47.1 percent for PBSC transplant. For patients with chronic myeloid leukemia, the rates were 40.2 percent for bone marrow transplant and 48.5 percent for PBSC transplant.

"This update comparing two important stem cell sources did not find differences in survival after 10-year follow-up. However, subgroup analyses did reveal notable differences in survival in patients with acute leukemias between those who received allogeneic blood cells and those who received bone marrow, while no differences were seen in patients with chronic myeloid leukemia, the researchers wrote.

"Our observations support previous reports that different patient groups might still benefit from transplantation with bone marrow," they concluded.

The study was published online Jan. 31 in The Lancet Oncology.

More information

The U.S. National Cancer Institute has more about leukemia.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, Jan. 31, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
2. ACell, Inc. Founder Mentioned on the Oprah Winfrey Show as Inventor of Powder for Healing Severed Fingers
3. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
4. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
5. Oral drug sets a new survival standard for bone marrow cancer
6. Bone marrow cell transplants help nerve regeneration
7. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
8. Transplanted Bone Marrow Cells Aid Nerve Regeneration
9. Stem cells make bone marrow cancer resistant to treatment
10. Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation
11. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
(Date:2/23/2017)... IPSWICH, Mass. (PRWEB) , ... February 23, 2017 ... ... chosen as an approved content provider for the National Institute for Health ... care and social care-related organizations in the National Health Service (NHS) to search, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
(Date:2/23/2017)... ... ... CALNOC, the nation’s first and only nursing quality indicators database today announced ... and Collaboration – in Seattle, WA on October 23, 2017. , Dr. Gary Kaplan ... Seattle since 2000. In addition to his role at Virginia Mason, Dr. Kaplan also ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... drug pricing data and benchmarks in the global Autism Spectrum Disorder ... What are the key drugs marketed for Autism Spectrum ...
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
Breaking Medicine Technology: